Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for WARFARIN SODIUM

Ingredient

WARFARIN SODIUM

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-WARFARIN	1MG	TABLET	Resolved	2024-04-19	2024-05-15	225782
APO-WARFARIN	1MG	TABLET	Resolved	2024-06-13	2024-08-16	230483
APO-WARFARIN	2MG	TABLET	Resolved	2020-05-13	2020-07-28	114975
APO-WARFARIN	2MG	TABLET	Resolved	2025-08-28	2025-09-26	266078
APO-WARFARIN	2.5MG	TABLET	Resolved	2020-01-08	2020-06-08	102666
APO-WARFARIN	2.5MG	TABLET	Resolved	2020-01-08	2020-06-08	102671
APO-WARFARIN	10MG	TABLET	Resolved	2020-05-13	2020-06-22	114970
COUMADIN TAB 10MG	10MG	TABLET	Resolved	2018-06-05	2018-12-07	51538
COUMADIN TAB 10MG	10MG	TABLET	Resolved	2018-02-07	2018-05-08	38962
COUMADIN TAB 10MG	10MG	TABLET	Avoided shortage	2020-01-09	2020-04-20	102887

Previous
1
2
3
4
…
6
Next

Showing 11 to 20 of 56

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TARO-WARFARIN	2.5MG	TABLET	Discontinued	2019-11-01	2019-11-02	97862
TARO-WARFARIN	2MG	TABLET	Discontinued	2021-08-24	2021-08-24	144558

Showing 21 to 22 of 22